152 related articles for article (PubMed ID: 15346899)
1. [Morphology and neurotoxicity of newly identified spherical beta-amyloid aggregates, 'amylospheroid', aiming at elucidation of the neurodegenerative cascades in Alzheimer's disease].
Hoshi M
Seikagaku; 2004 Jul; 76(7):631-9. PubMed ID: 15346899
[No Abstract] [Full Text] [Related]
2. [Alzheimer's disease: cellular and molecular aspects].
Octave JN; Pierrot N
Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: Mental plaque removal.
De Strooper B; Woodgett J
Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
[No Abstract] [Full Text] [Related]
4. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta.
Hoshi M; Sato M; Matsumoto S; Noguchi A; Yasutake K; Yoshida N; Sato K
Proc Natl Acad Sci U S A; 2003 May; 100(11):6370-5. PubMed ID: 12750461
[TBL] [Abstract][Full Text] [Related]
5. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in Alzheimer's disease].
Morishima-Kawashima M; Ihara Y
Seikagaku; 2001 Nov; 73(11):1297-307. PubMed ID: 11831025
[No Abstract] [Full Text] [Related]
7. Compensatory responses induced by oxidative stress in Alzheimer disease.
Moreira PI; Zhu X; Liu Q; Honda K; Siedlak SL; Harris PL; Smith MA; Perry G
Biol Res; 2006; 39(1):7-13. PubMed ID: 16629160
[TBL] [Abstract][Full Text] [Related]
8. DYRK1A inhibition as potential treatment for Alzheimer's disease.
Stotani S; Giordanetto F; Medda F
Future Med Chem; 2016 Apr; 8(6):681-96. PubMed ID: 27073990
[TBL] [Abstract][Full Text] [Related]
9. [Brain aging and insulin signals].
Takashima A
Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):137-40. PubMed ID: 15855731
[No Abstract] [Full Text] [Related]
10. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
11. The biochemical study on the etiology of Alzheimer's disease.
Imahori K
Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(1):54-61. PubMed ID: 20075608
[TBL] [Abstract][Full Text] [Related]
12. Beta amyloid neurotoxicity and neuronal degeneration in Alzheimer's disease.
Kowall NW
Neurobiol Aging; 1994; 15(2):257-8. PubMed ID: 7838305
[No Abstract] [Full Text] [Related]
13. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
Phiel CJ; Wilson CA; Lee VM; Klein PS
Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
[TBL] [Abstract][Full Text] [Related]
14. Role of amyloid beta-protein in Alzheimer's disease.
Barker A
Lancet; 1992 Oct; 340(8823):850-1. PubMed ID: 1357268
[No Abstract] [Full Text] [Related]
15. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
Koh SH; Noh MY; Kim SH
Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
[TBL] [Abstract][Full Text] [Related]
16. [Alzheimer's disease and neuronal death].
Yanagisawa K
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1712-6. PubMed ID: 10581751
[No Abstract] [Full Text] [Related]
17. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
18. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
19. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
Avila J; Wandosell F; Hernández F
Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
Querfurth HW; LaFerla FM
N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
